img

Global Soliris Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Soliris Drug Market Insights, Forecast to 2034

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Global Soliris Drug market is expected to reach to US$ 3010 million in 2024, with a positive growth of %, compared with US$ 3762 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Soliris Drug industry is evaluated to reach US$ 1746.8 million in 2029. The CAGR will be -8.7% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Soliris Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Soliris Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Segment by Type
Plasma Exchange
Plasma Infusion

Segment by Application


PNH
aHUS
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Soliris Drug plant distribution, commercial date of Soliris Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Soliris Drug introduction, etc. Soliris Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Soliris Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Soliris Drug Product Introduction
1.2 Market by Type
1.2.1 Global Soliris Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 PNH
1.3.3 aHUS
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Soliris Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Soliris Drug Revenue by Region
2.2.1 Global Soliris Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Soliris Drug Revenue by Region (2018-2024)
2.2.3 Global Soliris Drug Revenue by Region (2024-2029)
2.2.4 Global Soliris Drug Revenue Market Share by Region (2018-2029)
2.3 Global Soliris Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Soliris Drug Sales by Region
2.4.1 Global Soliris Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Soliris Drug Sales by Region (2018-2024)
2.4.3 Global Soliris Drug Sales by Region (2024-2029)
2.4.4 Global Soliris Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Soliris Drug Sales by Manufacturers
3.1.1 Global Soliris Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Soliris Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Soliris Drug in 2022
3.2 Global Soliris Drug Revenue by Manufacturers
3.2.1 Global Soliris Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Soliris Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Soliris Drug Revenue in 2022
3.3 Global Key Players of Soliris Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Soliris Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Soliris Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Soliris Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Soliris Drug, Product Offered and Application
3.8 Global Key Manufacturers of Soliris Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Soliris Drug Sales by Type
4.1.1 Global Soliris Drug Historical Sales by Type (2018-2024)
4.1.2 Global Soliris Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Soliris Drug Sales Market Share by Type (2018-2029)
4.2 Global Soliris Drug Revenue by Type
4.2.1 Global Soliris Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Soliris Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Soliris Drug Revenue Market Share by Type (2018-2029)
4.3 Global Soliris Drug Price by Type
4.3.1 Global Soliris Drug Price by Type (2018-2024)
4.3.2 Global Soliris Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Soliris Drug Sales by Application
5.1.1 Global Soliris Drug Historical Sales by Application (2018-2024)
5.1.2 Global Soliris Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Soliris Drug Sales Market Share by Application (2018-2029)
5.2 Global Soliris Drug Revenue by Application
5.2.1 Global Soliris Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Soliris Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Soliris Drug Revenue Market Share by Application (2018-2029)
5.3 Global Soliris Drug Price by Application
5.3.1 Global Soliris Drug Price by Application (2018-2024)
5.3.2 Global Soliris Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Soliris Drug Market Size by Type
6.1.1 US & Canada Soliris Drug Sales by Type (2018-2029)
6.1.2 US & Canada Soliris Drug Revenue by Type (2018-2029)
6.2 US & Canada Soliris Drug Market Size by Application
6.2.1 US & Canada Soliris Drug Sales by Application (2018-2029)
6.2.2 US & Canada Soliris Drug Revenue by Application (2018-2029)
6.3 US & Canada Soliris Drug Market Size by Country
6.3.1 US & Canada Soliris Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Soliris Drug Sales by Country (2018-2029)
6.3.3 US & Canada Soliris Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Soliris Drug Market Size by Type
7.1.1 Europe Soliris Drug Sales by Type (2018-2029)
7.1.2 Europe Soliris Drug Revenue by Type (2018-2029)
7.2 Europe Soliris Drug Market Size by Application
7.2.1 Europe Soliris Drug Sales by Application (2018-2029)
7.2.2 Europe Soliris Drug Revenue by Application (2018-2029)
7.3 Europe Soliris Drug Market Size by Country
7.3.1 Europe Soliris Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Soliris Drug Sales by Country (2018-2029)
7.3.3 Europe Soliris Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Soliris Drug Market Size
8.1.1 China Soliris Drug Sales (2018-2029)
8.1.2 China Soliris Drug Revenue (2018-2029)
8.2 China Soliris Drug Market Size by Application
8.2.1 China Soliris Drug Sales by Application (2018-2029)
8.2.2 China Soliris Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Soliris Drug Market Size by Type
9.1.1 Asia Soliris Drug Sales by Type (2018-2029)
9.1.2 Asia Soliris Drug Revenue by Type (2018-2029)
9.2 Asia Soliris Drug Market Size by Application
9.2.1 Asia Soliris Drug Sales by Application (2018-2029)
9.2.2 Asia Soliris Drug Revenue by Application (2018-2029)
9.3 Asia Soliris Drug Sales by Region
9.3.1 Asia Soliris Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Soliris Drug Revenue by Region (2018-2029)
9.3.3 Asia Soliris Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Soliris Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Soliris Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Soliris Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Soliris Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Soliris Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Soliris Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Soliris Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Soliris Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Soliris Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Soliris Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Soliris Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AstraZeneca Soliris Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Soliris Drug Industry Chain Analysis
12.2 Soliris Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Soliris Drug Production Mode & Process
12.4 Soliris Drug Sales and Marketing
12.4.1 Soliris Drug Sales Channels
12.4.2 Soliris Drug Distributors
12.5 Soliris Drug Customers
13 Market Dynamics
13.1 Soliris Drug Industry Trends
13.2 Soliris Drug Market Drivers
13.3 Soliris Drug Market Challenges
13.4 Soliris Drug Market Restraints
14 Key Findings in The Global Soliris Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Soliris Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Plasma Exchange
Table 3. Major Manufacturers of Plasma Infusion
Table 4. Global Soliris Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Soliris Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Soliris Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Soliris Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Soliris Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Soliris Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Soliris Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Soliris Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Soliris Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Soliris Drug Sales Market Share by Region (2018-2024)
Table 14. Global Soliris Drug Sales Market Share by Region (2024-2029)
Table 15. Global Soliris Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Soliris Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Soliris Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Soliris Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Soliris Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Soliris Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Soliris Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Soliris Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris Drug as of 2022)
Table 23. Global Key Manufacturers of Soliris Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Soliris Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Soliris Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Soliris Drug Sales Share by Type (2018-2024)
Table 30. Global Soliris Drug Sales Share by Type (2024-2029)
Table 31. Global Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Soliris Drug Revenue Share by Type (2018-2024)
Table 34. Global Soliris Drug Revenue Share by Type (2024-2029)
Table 35. Soliris Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Soliris Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Soliris Drug Sales Share by Application (2018-2024)
Table 40. Global Soliris Drug Sales Share by Application (2024-2029)
Table 41. Global Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Soliris Drug Revenue Share by Application (2018-2024)
Table 44. Global Soliris Drug Revenue Share by Application (2024-2029)
Table 45. Soliris Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Soliris Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Soliris Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Soliris Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Soliris Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Soliris Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Soliris Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Soliris Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Soliris Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Soliris Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Soliris Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Soliris Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Soliris Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Soliris Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Soliris Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Soliris Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Soliris Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Soliris Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Soliris Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Soliris Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Soliris Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Soliris Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Soliris Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Soliris Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Soliris Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Soliris Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Soliris Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Soliris Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Soliris Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Soliris Drug Sales by Country (2024-2029) & (K Units)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Soliris Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AstraZeneca Soliris Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Soliris Drug Distributors List
Table 115. Soliris Drug Customers List
Table 116. Soliris Drug Market Trends
Table 117. Soliris Drug Market Drivers
Table 118. Soliris Drug Market Challenges
Table 119. Soliris Drug Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Soliris Drug Product Picture
Figure 2. Global Soliris Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Soliris Drug Market Share by Type in 2022 & 2029
Figure 4. Plasma Exchange Product Picture
Figure 5. Plasma Infusion Product Picture
Figure 6. Global Soliris Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Soliris Drug Market Share by Application in 2022 & 2029
Figure 8. PNH
Figure 9. aHUS
Figure 10. Other
Figure 11. Soliris Drug Report Years Considered
Figure 12. Global Soliris Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Soliris Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Soliris Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Soliris Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Soliris Drug Sales 2018-2029 ((K Units)
Figure 17. Global Soliris Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Soliris Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Soliris Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Soliris Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Soliris Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Soliris Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Soliris Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Soliris Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Soliris Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Soliris Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Soliris Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Soliris Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Soliris Drug in the World: Market Share by Soliris Drug Revenue in 2022
Figure 30. Global Soliris Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Soliris Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Soliris Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Soliris Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Soliris Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Soliris Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Soliris Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Soliris Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Soliris Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Soliris Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Soliris Drug Sales Share by Country (2018-2029)
Figure 49. Germany Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 51. UK Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Soliris Drug Sales Market Share by Type (2018-2029)
Figure 55. China Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Soliris Drug Sales Market Share by Application (2018-2029)
Figure 57. China Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Soliris Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Soliris Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Soliris Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Soliris Drug Sales Share by Region (2018-2029)
Figure 64. Japan Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Soliris Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Soliris Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Soliris Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Soliris Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Soliris Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Soliris Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Soliris Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Soliris Drug Value Chain
Figure 81. Soliris Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed